Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intelligent Bio Solutions Inc. - Common Stock (NQ:INBS)

1.290 -0.010 (-0.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 52,183
Open 1.310
Bid (Size) 1.260 (1)
Ask (Size) 1.320 (28)
Prev. Close 1.300
Today's Range 1.250 - 1.310
52wk Range 1.000 - 3.040
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology
Intelligent Bio Solutions (INBS) received a U.S. patent for its fingerprint drug screening technology, expanding its intellectual property portfolio. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch
Intelligent Bio Solutions awaits FDA clearance for its fingerprint drug test, aiming for a 2025 U.S. launch and expanding its presence in the multi-billion market. 
Via Benzinga
Exposures Product Safety

Performance

YTD
-8.5%
-8.5%
1 Month
-22.8%
-22.8%
3 Month
-11.0%
-11.0%
6 Month
-17.3%
-17.3%
1 Year
-47.8%
-47.8%

More News

Read More
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
Via ACCESS Newswire
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Which stocks are moving after the closing bell on Wednesday?
Via Chartmill
EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales
Via Benzinga
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
Via FinancialNewsMedia
Topics Cannabis Death
Exposures Cannabis Death
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
From FN Media Group LLC
Via GlobeNewswire
EXCLUSIVE: Intelligent Bio Solutions Partners With UK-Based Quantum TM For Fingerprint Drug Testing At 10 Sites
Via Benzinga
EXCLUSIVE: Intelligent Bio Solutions Partners With IVY Diagnostics, Seeks Expansion In Europe's $3.6 Billion Drug Screening Market
Via Benzinga
Harry Simeonidis, CEO of Intelligent Bio Solutions Inc. (NASDAQ: INBS), to Present at NobleCon20
Via Investor Brand Network
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach
Via NewMediaWire
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach
Via TheNewswire.com
Stocks Driving Market Momentum with Groundbreaking Contracts and Technologies: LUNR, PRSO, LPTH, INBS, PNPN.V
Via AB Newswire
Topics Economy Emissions Energy
Exposures Economy Electricity Generation Intellectual Property
Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
“Intelligent Bio (NASDAQ: INBS), SINTX Technologies (NASDAQ: SINT) Lead Market Surge, and Piedmont, Kaival, Peraso Show Strong Potential”
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
“Stocks to Watch Showing Strong Market Potential INBS, NANO.T, MLGO, KAVL, PNPN.V”
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July
Via Benzinga
What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday?
Via Benzinga
Exposures Product Safety
US Stocks Higher; Dow Surges Over 200 Points
Via Benzinga
Topics Stocks
Exposures US Equities
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Growth Stocks Across Multiple Sectors-Innovators in Action: MODD, INBS, RCAT, KAVL, WHLR”
Via AB Newswire
Exposures Product Safety
Fit to Work: Intelligent Bio Solutions’ (NASDAQ: INBS) Vision for a Healthier, Safer Workplace WISA, BFLY, CLOV, PRSO
Via AB Newswire
A New Standard in Drug Testing: Intelligent Bio (NASDAQ: INBS) Delivering Cost-Efficiency, Rapid Results, and Employee Dignity more stocks inside…
Via AB Newswire

Frequently Asked Questions

Is Intelligent Bio Solutions Inc. - Common Stock publicly traded?
Yes, Intelligent Bio Solutions Inc. - Common Stock is publicly traded.
What exchange does Intelligent Bio Solutions Inc. - Common Stock trade on?
Intelligent Bio Solutions Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Intelligent Bio Solutions Inc. - Common Stock?
The ticker symbol for Intelligent Bio Solutions Inc. - Common Stock is INBS on the Nasdaq Stock Market
What is the current price of Intelligent Bio Solutions Inc. - Common Stock?
The current price of Intelligent Bio Solutions Inc. - Common Stock is 1.290
When was Intelligent Bio Solutions Inc. - Common Stock last traded?
The last trade of Intelligent Bio Solutions Inc. - Common Stock was at 04/25/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.